Volume 16, Number 3—March 2010
Dispatch
Paenibacillus larvae Bacteremia in Injection Drug Users
Table
Characteristic | Patient no. |
||||
---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | |
Age, y/sex | 28/F | 32/M | 20/M | 35/M | 27/F |
Date evaluated | 2003 Jul | 2003 Sep | 2003 Oct | 2004 Feb | 2008 May |
Clinical samples with identification of P. larvae† | Culture of ascites (2003 Jul), blood culture (2003 Aug) | Blood culture | Blood culture | Blood culture | Blood culture |
CRP, mg/L | 43 | 17 | 11 | 37 | 40 |
Leukocyte count, × 109/L | 23.0 | 13.0 | 9.3 | 11.8 | 19.2 |
Medical history | IVDA, hepatitis C, Child B liver cirrhosis with refractory ascites | IVDA, hepatitis C, hepatitis B | IVDA, hepatitis C | IVDA, hepatitis C, history of hepatitis A | IVDA, hepatitis C, alcohol abuse |
Clinical signs and symptoms | Decompensated liver cirrhosis, ascites, fever (39.2°C) | Persistent weakness and malaise, fever (39.2°C) | Somnolence, fever (38.2°C) | Tachypnoe, right-sided pleuritic chest pain, fever (37.8°C) | Severe anemia, spontaneous mucosal bleeding, fever (39.8°C) |
Clinical conditions other than bacteremia | Bacterial peritonitis, hepatic encephalopathy after TIPS placement | Acute hepatitis B diagnosed 1 mo before bacteremia, eosinophilia | Methadone/ diazepam overdose | Pulmonary embolism, infarction pneumonia, deep vein thrombosis | Subsequently diagnosed with ITP, Paracoccus yeei and Micrococcus luteus bacteremia |
Treatment (duration) | Meropenem (7 d) followed by ampicillin IV (2 d), then meropenem (7 d) followed by penicillin G (14 d) | None | None | Cefuroxim IV (7 d) | Imipenem (21 d) |
*CRP, C-reactive protein (reference range <5 mg/L); IVDA, intravenous drug abuse; TIPS, transjugular intrahepatic portosystemic shunt; ITP, idiopathic thrombocytopenic purpura; IV, intravenous.
†P. larvae identified after culture using 16S rRNA gene sequencing.
Page created: December 14, 2010
Page updated: December 14, 2010
Page reviewed: December 14, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.